Generation and characterization of induced pluripotent stem cell line (IGIBi001-A) from a sickle cell anemia patient with homozygous β-globin mutation
Summary
Sickle cell disease (SCD) is an autosomal recessive disorder caused by a mutation in β-globin (HBB) gene. We have generated an induced pluripotent stem cell (iPSC) line, IGIBi001-A from an Indian sickle cell patient with a homozygous HBB gene mutation using Sendai virus reprogramming system. Characterization of IGIBi001-A showed that these iPSCs are transgene-free and expressed pluripotent stem cell markers. They had a normal karyotype and were able to differentiate into all three germ layers. This new SCD-iPSC line will contribute to better understanding of the disease biology of sickle cell anemia and for screening of small molecule drugs. Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
| Authors | Bhargava N, Jaitly S, Goswami SG, Jain S, Chakraborty D, Ramalingam S |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2019 Aug;39:101484 |
| PubMed | 31255831 |
| DOI | 10.1016/j.scr.2019.101484 |